Replies to post #277 on Ventrus Biosciences Inc. (VTUS)

[ottoman]

..."the U.S. Food and Drug Administration (FDA) has scheduled a Type B pre-NDA meeting on Thursday, June 19, 2014 at which the company will seek guidance on its planned new drug application (NDA) for DOLIZEM (diltiazem hydrochloride cream) in anal fissures."


I think I need a cream for anal fissures after buying this POS stock

LMAO!!